After Failed Cephalon Bid, Valeant Buys Sanitas For $443M
Less than a month after getting outbid by Teva Pharmaceutical Industries Ltd. for Cephalon Inc., Valeant Pharmaceuticals International Inc. made good Tuesday on its promise to find other targets, snapping up...To view the full article, register now.
Already a subscriber? Click here to view full article